CG6-27049-27892
4 vaccinations
1 coded response
49 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 967 / HI
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-25
- 2021-04-14
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-08
- 2021-10-13
- 2021-10-20
- 2021-10-28
- 2021-11-05
- 2021-11-12
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Fatigue, Headache — Feeling: GoodFree text: Fatigue, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
-
2022-05-26
Dose 4 — Pfizer-BioNTech
- 2022-05-26
-
2022-05-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-05-29
-
2022-05-30
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-31
- 2022-06-01
- 2022-06-04
- 2022-06-09
- 2022-06-16
- 2022-06-25
- 2022-06-30
- 2022-07-07
- 2022-08-25
- 2022-11-26
- 2023-05-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-05-26 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Fatigue, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release